Crossmark

Therapeutic indications and other use-case-driven updates in the drug ontology: anti-malarials, anti-hypertensives, opioid analgesics, and a large term request

Crossref DOI link: https://doi.org/10.1186/s13326-017-0121-5

Published Online: 2017-03-03

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hogan, William R.

Hanna, Josh

Hicks, Amanda

Amirova, Samira

Bramblett, Baxter

Diller, Matthew

Enderez, Rodel

Modzelewski, Timothy

Vasconcelos, Mirela

Delcher, Chris
Funding

Funding for this research was provided by:

Patient-Centered Outcomes Research Institute (CDRN-1501-26692)

National Center for Advancing Translational Sciences (UL1TR000064)
License Information

Text and Data Mining valid from 2017-03-03

Version of Record valid from 2017-03-03
More Information

Article History

Received: 11 November 2016

Accepted: 24 February 2017

First Online: 3 March 2017

Document is current

Any future updates will be listed below